HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
Authors:
Open Access
- 31 March 2021
- journal article
- review article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (6) , e23755
Abstract
Objective: To discuss the clinical significance of HCV‐cAg testing in the diagnosis, activity determination, and monitoring of therapeutic effectiveness of HCV infection and its advantages compared with HCV‐RNA and anti‐HCV antibodies detection.Methods: By summarizing the published literature, the advantages and significance of HCV core antigen detection were sought.Results: The expression of HCV‐cAg is highly consistent with that of HCV‐RNA, but compared with HCV‐RNA, detection of HCV‐cAg is easy to operate, time saving, and low cost. HCV‐cAg can be detected within 12~15 days after infection, and the window period can be shortened by5~7 weeks. HCV‐cAg is a serological indicator of virus replication, which can distinguish previous infection of HCV or current infection. HCV‐cAg detection is more suitable for immunocompromised, hemodialysis, organ transplant patients. HCV‐cAg also can be used to monitor antiviral efficacy and predict sustained virological response (SVR).Conclusion: HCV core antigen has similar clinical sensitivity to NAT and can be used as a substitute for HCV‐RNA in the diagnosis of virus infection. Combined detection of HCV‐cAg and antibody serology can help doctors detect HCV infection earlier, accurately diagnose different stages of HCV infection, and evaluate the therapeutic effect of antiviral drugs, which are beneficial in the prevention and treatment of hepatitis C.Keywords
This publication has 49 references indexed in Scilit:
- Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatmentWorld Journal of Gastroenterology, 2014
- Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings?The Brazilian Journal of Infectious Diseases, 2013
- Therapy‐induced clearance of HCV core antigen from plasma predicts an end of treatment viral responseJournal of Viral Hepatitis, 2012
- Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individualsAntiviral Therapy, 2012
- Hepatitis C virus core antigen: Analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassayJournal of Clinical Virology, 2011
- Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis PatientsBrazilian Journal of Microbiology, 2011
- Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patientsJournal of Clinical Virology, 2010
- Frequent HCV reinfection and superinfection in a cohort of injecting drug users in AmsterdamJournal of Hepatology, 2009
- Very low hepatitis C antibody levels predict false‐positive results and avoid supplemental testingTransfusion, 2008
- Variable Ratio of Hepatitis C Virus RNA to Viral Core Antigen in Patient SeraJournal of Clinical Microbiology, 2004